Moreover, lower GAS5 levels have been associated with increased risk of AF recurrence after radiofrequency catheter ablation, highlighting its potential as both a mechanistic regulator and a prognostic biomarker for AF progression and therapeutic outcomes [17, 18]. The gene discussed is GAS5; the disease is atrial fibrillation.